Abstract
Overview
Introduction
Technology markets are changing fast. This brief identifies and tracks the key
forces shaping the prospects for your business. In this piece, Datamonitor' s
analyst specializing in pharmaceutical technology will outline the changes in
the market, explain which trends will have the biggest impact, and highlight
who will benefit from the fast-paced developments in pharmaceutical technology.
Scope
- An overview of the challenges facing the life science industry in 2008
- Datamonitor' s take on the technology priorities of pharmaceutical and
biotechnology companies
- Strategies to help technology vendors penetrate the life science industry
Report Highlights
As the specter of generic competition grows, streamlining operations to reduce
costs and time-to-market of a drug will be a top priority for pharmaceutical
companies.
The life science industry must embrace technology solutions as it shifts away
from the "blockbuster drug" business model.
Data management is a key issue affecting the life sciences. As drug regulatory
agencies demand more clinical and post-market data, clinical IT solutions will
become crucial to the industry.
Reasons to Purchase
- Learn about the top trends in the life science industry in 2008
- Identify strategies for expanding business opportunities in the life
science industry
- Tailor your go-to-market strategy to address critical issues facing
pharmaceutical and biotechnology companies
View Cart
